F-105

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameF-105
Drug Alias NameMonoclonal antibody F105F-105
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionT-cell surface antigen CD4 inhibitorsEnvelope glycoprotein gp160 inhibitors
TargetsEnvelope glycoprotein gp160T-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCentocor
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentocorNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A